Latest Updates on ANAB
-
IPOs Don't Wait for the Ginkgo Bioworks IPO to Profit from This $3 Billion Industry
After making Forbes list for the next billion-dollar startup, anxious investors are hoping a Ginkgo Bioworks IPO is in the works. That's because biotech and healthcare IPOs are netting investors gains as much as 300% so far in 2017. Read more » -
IPOs IPO News: Is This Extremely Secretive $4.7 Billion Company About to Go Public?
In recent IPO news, Wall Street is buzzing about a secretive company that could go public. This biotech firm is valued by some at $4.7 billion, despite not having any products on the market. Read more »
